These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 35235144)
1. Effect of thyroid function on pre-β1 high-density lipoprotein levels in patients with Graves' disease undergoing radioiodine treatment. Cai Z; Deng L; Chen Y; Ling Y Endocrine; 2022 Jun; 76(3):648-659. PubMed ID: 35235144 [TBL] [Abstract][Full Text] [Related]
2. Serum Thyroid Hormone Balance in Levothyroxine Monotherapy-Treated Patients with Atrophic Thyroid After Radioiodine Treatment for Graves' Disease. Ito M; Kawasaki M; Danno H; Kohsaka K; Nakamura T; Hisakado M; Yoshioka W; Kasahara T; Kudo T; Nishihara E; Fukata S; Nishikawa M; Nakamura H; Miyauchi A Thyroid; 2019 Oct; 29(10):1364-1370. PubMed ID: 31411123 [No Abstract] [Full Text] [Related]
3. [Radioiodine treatment of hyperthyroidism using a simplified dosimetric approach. Clinical results]. Giovanella L; De Palma D; Ceriani L; Vanoli P; Garancini S; Tordiglione M; Tarolo GL Radiol Med; 2000 Dec; 100(6):480-3. PubMed ID: 11307510 [TBL] [Abstract][Full Text] [Related]
4. Radioiodine therapy compared in patients with toxic nodular or Graves' hyperthyroidism. Franklyn JA; Daykin J; Holder R; Sheppard MC QJM; 1995 Mar; 88(3):175-80. PubMed ID: 7767667 [TBL] [Abstract][Full Text] [Related]
5. Effect of thyroid dysfunction on high-density lipoprotein subfraction metabolism: roles of hepatic lipase and cholesteryl ester transfer protein. Tan KC; Shiu SW; Kung AW J Clin Endocrinol Metab; 1998 Aug; 83(8):2921-4. PubMed ID: 9709970 [TBL] [Abstract][Full Text] [Related]
6. [Treatment of hyperthyroidism caused by Graves' disease or toxic multinodular goitre by radioiodine: over 80% cure retrospectively after one calculated dose]. Bakker SC; Zanin DE; Zweers EJ Ned Tijdschr Geneeskd; 2002 Sep; 146(39):1837-41. PubMed ID: 12382370 [TBL] [Abstract][Full Text] [Related]
7. Radioactive iodine therapy for pediatric Graves' disease: a single-center experience over a 10-year period. Kaplowitz PB; Jiang J; Vaidyanathan P J Pediatr Endocrinol Metab; 2020 Mar; 33(3):383-389. PubMed ID: 31603857 [TBL] [Abstract][Full Text] [Related]
8. Outcome of thyroid function in Graves' patients treated with radioiodine: role of thyroid-stimulating and thyrotropin-blocking antibodies and of radioiodine-induced thyroid damage. Chiovato L; Fiore E; Vitti P; Rocchi R; Rago T; Dokic D; Latrofa F; Mammoli C; Lippi F; Ceccarelli C; Pinchera A J Clin Endocrinol Metab; 1998 Jan; 83(1):40-6. PubMed ID: 9435414 [TBL] [Abstract][Full Text] [Related]
9. Graves' Disease: Can It Be Cured? Wiersinga WM Endocrinol Metab (Seoul); 2019 Mar; 34(1):29-38. PubMed ID: 30912336 [TBL] [Abstract][Full Text] [Related]
10. Effects of radioiodine therapy in hyperthyroidism (thyroid function, thyroid volume, Graves' ophtalmopathy, thyrotoxic heart disease). Ursu HI; Dumitriu L; Grigorie D; Simescu M; Vaida E; Belgun M; Popovici D Rom J Endocrinol; 1993; 31(3-4):155-63. PubMed ID: 7697064 [TBL] [Abstract][Full Text] [Related]
11. Changes in plasma low-density lipoprotein (LDL)- and high-density lipoprotein cholesterol in hypo- and hyperthyroid patients are related to changes in free thyroxine, not to polymorphisms in LDL receptor or cholesterol ester transfer protein genes. Diekman MJ; Anghelescu N; Endert E; Bakker O; Wiersinga WM J Clin Endocrinol Metab; 2000 May; 85(5):1857-62. PubMed ID: 10843165 [TBL] [Abstract][Full Text] [Related]
12. The development of transient hypothyroidism after iodine-131 treatment in hyperthyroid patients with Graves' disease: prevalence, mechanism and prognosis. Aizawa Y; Yoshida K; Kaise N; Fukazawa H; Kiso Y; Sayama N; Hori H; Abe K Clin Endocrinol (Oxf); 1997 Jan; 46(1):1-5. PubMed ID: 9059550 [TBL] [Abstract][Full Text] [Related]
13. Ultrasonographic thyroid volume as a reliable prognostic index of radioiodine-131 treatment outcome in Graves' disease hyperthyroidism. Gómez-Arnaiz N; Andía E; Gumà A; Abós R; Soler J; Gómez JM Horm Metab Res; 2003 Aug; 35(8):492-7. PubMed ID: 12953167 [TBL] [Abstract][Full Text] [Related]
14. Pattern of recovery of the hypothalamic-pituitary-thyroid axis following radioactive iodine therapy in patients with Graves' disease. Uy HL; Reasner CA; Samuels MH Am J Med; 1995 Aug; 99(2):173-9. PubMed ID: 7625422 [TBL] [Abstract][Full Text] [Related]
16. Optimized radioiodine therapy of Graves' disease: analysis of the delivered dose and of other possible factors affecting outcome. Catargi B; Leprat F; Guyot M; Valli N; Ducassou D; Tabarin A Eur J Endocrinol; 1999 Aug; 141(2):117-21. PubMed ID: 10427153 [TBL] [Abstract][Full Text] [Related]
17. Three basic patterns of changes in serum thyroid hormone levels in Graves' disease during the one-year period after radioiodine therapy. Nakajo M; Tsuchimochi S; Tanabe H; Nakabeppu Y; Jinguji M Ann Nucl Med; 2005 Jun; 19(4):297-308. PubMed ID: 16097639 [TBL] [Abstract][Full Text] [Related]
18. Transient Hypothyroidism after Radioiodine for Graves' Disease: Challenges in Interpreting Thyroid Function Tests. Sheehan MT; Doi SA Clin Med Res; 2016 Mar; 14(1):40-5. PubMed ID: 26864507 [TBL] [Abstract][Full Text] [Related]